Tablet Formulation of Levothyroxine Is Absorbed Less Well Than Powdered Levothyroxine

Thyroid

Volumn 13, Issue 12, 2003, Pages 1177-1181

  Yamamoto, Toshihide ^a  

^a Thick Land Building   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LEVOTHYROXINE SODIUM; THYRADIN;

ADULT; ARTICLE; CASE REPORT; CONGENITAL HYPOTHYROIDISM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; FEMALE; GASTROINTESTINAL DISEASE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; POWDER; PRIORITY JOURNAL; TABLET FORMULATION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0346102449     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250360731596     Document Type: Article

References (20)

1. Kabadi UM 1989 Optimal daily thyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes. Arch Intern Med 149:2209-2212.
2. Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HPW, Fishman S, Larsen PR 2000 Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185-189.
3. Frey H, Johannesen O, Kapelrud H, Sand T 1987 Appropriate replacement dose of thyroxine in primary hypothyroidism. Acta Med Scand 222:163-167.
4. Hennessey JV, Evaul JE, Tseng T-C, Burman KD, Wartofsky L 1986 L-thyroxine dosage: A re-evaulation of therapy with contemporary preparation. Ann Intern Med 105:11-15.
5. Hays MT 1988 Thyroid hormone and gut. Endocr Res 14:203-224.
6. Harmon S, Siefert CF 1991 Levothyroxine-cholestyramine interaction reemphasized. Ann Intern Med 115:658-659.
7. Sperber AD, Liel Y 1992 Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med 152:183-184.
8. Campbell NRC, Hasinoff BB, Stalts H, Rao B, Wong NCW 1992 Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 117:1010-1013.
9. Havrankova J, Lahaie R 1992 Levothyroxine binding by sucralfate. Ann Intern Med 117:445-446.
10. McLean M, Kirkwood I, Epstein M, Jones B, Hall R 1993 Cation-exchange resin and inhibition of intestinal absorption of throxine. Lancet 341:1286.
11. Singh N, Singh PN, Hershman JM 2000 Effect of calcium carbonate of the absorption of levothyroxine. JAMA 283:2822-2825.
12. Liel Y, Harman-Boehm I, Shany S 1996 Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab 81:857-859.
13. Ain KB, Refetoff S, Fein HG, Weintraub BD 1991 Pseudomalabsorption of levothyroxine. JAMA 266:2118-2120.
14. Ogawa D, Otsuka F, Mimura Y, Ueno A, Hashimoto H, Kishida M, Ogura T, Makino H 2000 Pseudomalabsorption of levothyroxine: A case report. Endocr J 47:45-50.
15. Payer J, Sladekova K, Kinova S, Cesnakova Z, Killinger Z, Krizko M, Klimes I, Langer P 2000 Autoimmune thyroiditis with severe hypothyroidism resistant to the treatment with high peroral doses of thyroxine: Case report. Endocr Regul 34:189-193.
16. Eledrisi MS, Szymajda A, Alshanti M, Urban RJ 2001 Noncompliance with medical treatment: Pseudomalabsorption of levothyroxine. South Med J 94:833-836.
17. Jauk B, Mikosch P, Gallowitsch HJ, Kresnik E, Molnar M, Gomez I, Lind P 2000 Unusual malabsorption of levo-thyroxine. Thyroid 10:93-95.
18. Kubota S, Fukata S, Matsuzuka F, Kuma K, Miyauchi A 2003 Successful management of a patient with pseudomalab-sorption of levothyroxine. Int J Psych Med 33:183-188.
19. Hays MT 1968 Absorption of oral thyroxine in man. J Clin Endocrinol 28:749-756.
20. Hays MT 1991 Localization of human thyroxine absorption. Thyroid 1:241-248.